Pharmacological characterization of the small molecule 03A10 as an inhibitor of α-synuclein aggregation for Parkinson’s disease treatment
Qing Wang(Zhujiang Hospital), Linyin Feng(Shanghai Institute of Materia Medica)
Cited by 21
Related Papers
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
|Brain|2021|262
Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
|Frontiers in Immunology|2021|110
Inhibition of Histone Deacetylase 3 (HDAC3) Mediates Ischemic Preconditioning and Protects Cortical Neurons against Ischemia in Rats
|Frontiers in Molecular Neuroscience|2016|60
JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss
|Journal of Neuroinflammation|2018|31